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ABSTRACT  
Background: Smoking prevalence is doubled among people with mental health problems and 
reaches 80% in inpatient, substance misuse and prison settings, widening inequalities in morbidity 
and mortality. As more institutions become smoke-free but most smokers relapse immediately 
post-discharge, we aimed to review interventions to maintain abstinence post-discharge.  
Methods: MEDLINE, EMBASE, PsycINFO, CINAHL, and Web of Science were searched from 
inception to May 2016 and randomised controlled trials (RCTs) and cohort studies conducted with 
adult smokers in prison, inpatient mental health or substance use treatment included. Risk of bias 
(study quality) was rated using the Effective Public Health Practice Project Tool. Behaviour change 
techniques (BCTs) were coded from published papers and manuals using a published taxonomy. 
Mantel-Haenszel random effects meta-analyses of RCTs used biochemically verified point-
prevalence smoking abstinence at a) longest and b) six-month follow-up. 
Results: Five RCTs (n=416 intervention, n=415 control) and five cohort studies (n=471) included. 
Regarding study quality, four RCTs were rated strong, one moderate; one cohort study was rated 
strong, one moderate, three weak. Most common BCTs were pharmacotherapy (n=8 nicotine 
replacement therapy, n=1 clonidine), problem solving, social support, and elicitation of pros and 
cons (each n=6); papers reported fewer techniques than manuals. Meta-analyses found effects in 
favour of intervention [a) RR=2.06, 95% CI: 1.30-3.27; b) RR=1.86, 95% CI: 1.04-3.31]. 
Conclusion: Medication and/or behavioural support can help maintain smoking abstinence 
beyond discharge from smoke-free institutions with high mental health comorbidity. However, the 
small evidence base tested few different interventions and reporting of behavioural interventions 
is often imprecise.  
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INTRODUCTION  
Smoking prevalence among people with mental health problems is about twice as high as in the 
population as a whole and increases with severity of illness, in some instances reaching up to 80% 
(McManus S, 2016, Royal College of Physicians and Royal College of Psychiatrists, 2013). Smoking 
prevalence in those with mental health problems has not seen the same decline as in the general 
population (Cook et al., 2014, Szatkowski and McNeill, 2015). Smoking is the main contributor to a 
gap in life expectancy of 8 to 22 years between those with and without mental health problems 
(Brown et al., 2010, Chang et al., 2011, Lawrence et al., 2013, Tam et al., 2016, Wahlbeck et al., 
2011). This affects a large number of people as it has been estimated that one third of smokers 
have a mental health problem (Royal College of Physicians and Royal College of Psychiatrists, 
2013). Prevalence of smoking and mental health problems is also higher among other 
disadvantaged groups, such as offenders and people with drug and alcohol dependence (Royal 
College of Physicians and Royal College of Psychiatrists, 2013) in prisons and substance use 
treatment settings, smoking prevalence in excess of 80% has been observed in some countries 
(Hickman et al., 2015). Evidence suggests that cessation benefits not just physical, but also mental 
health (Taylor et al., 2014).  
Recently, some efforts to address this inequality have been made, including the introduction of 
comprehensive smoke-free policies in secondary care settings and prisons (National Institute for 
Health and Care Excellence, 2013, Working Group for Improving the Physical Health of People with 
SMI, 2016), ideally involving both smoke-free policies in buildings and grounds and integrated 
treatment for temporary abstinence and quitting (Kleber et al., 2007, National Institute for Health 
and Care Excellence, 2013, Working Group for Improving the Physical Health of People with SMI, 
2016). Staying in a smoke-free facility can provide a possibly rare period of abstinence from 
smoking and provides an opportunity to initiate long-term change to reduce morbidity and 
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mortality. However, the risk of relapse after leaving is extremely high (Clarke et al., 2013, 
Prochaska et al., 2006) and there appears to be little routine support to maintain abstinence and 
little evidence on interventions that may reduce the risk of reverting to smoking. An existing 
review of interventions to maintain abstinence in hospitalised patients (Rigotti et al., 2012) 
specifically excluded patients from facilities that predominantly treat psychiatric conditions or 
substance abuse, meaning there is a particular lack of information on the extant evidence in these 
disadvantaged populations. One previous review summarised the impact of smoke-free psychiatric 
hospitalization on patients’ smoking (Stockings et al., 2014a). Institutions with incomplete smoke-
free policies that were not necessarily providing any behavioural or pharmacological support to 
achieve abstinence were included in the review and the authors concluded that adherence to the 
smoke-free policy and receipt of treatment are likely to be important factors for patients’ 
smoking.   
We aimed to systematically review randomised controlled trials and cohort studies to identify 
pharmacological or behavioural interventions provided during the stay or post-discharge to 
maintain abstinence in smokers after a period of enforced abstinence in smoke-free facilities for 
mental health, substance misuse treatment centres or prisons. A secondary aim was to identify 
intervention components to guide development of future interventions.   
 
METHODS 
The review is registered as PROSPERO 2016:CRD42016041840. 
Inclusion criteria 
The review included randomised controlled trials (including feasibility and pilot trials) and 
observational cohort studies with participants who were adult smokers (18 or older), abstinent 
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because of a stay in a smoke-free prison, mental health or substance use treatment centre and 
followed up post-discharge. Institutions with partial smoke-free policies were included if 
participants had no access to smoking areas. In addition to a smoke-free setting, at least minimal 
support had to be offered. This could include any type of behavioural or pharmacological 
intervention aimed at maintaining abstinence from smoking following discharge, delivered during 
the stay and/or post-discharge. No limits were applied to control conditions where applicable. 
Outcome measures  
Primary outcome:   
i. Biochemically verified continuous smoking abstinence at longest follow-up (West et al., 2005). 
Secondary outcomes:  
i. Biochemically verified continuous smoking abstinence at six months 
ii. Biochemically verified point-prevalence (seven-day) smoking abstinence at longest follow-up 
iii. Biochemically verified point-prevalence smoking abstinence at six months  
iv. Self-reported continuous abstinence at longest follow-up 
v. Self-reported continuous smoking abstinence at six months. 
vi. Self-reported point-prevalence abstinence at longest follow-up 
vii. Self-reported point prevalence smoking abstinence at six months 
viii. Other changes in smoking behaviour: a. Time to first cigarette post-discharge; b. Change in 
cigarette consumption at follow-up compared with the period prior to the enforced abstinence.  
Search strategy and selection of studies 
MEDLINE, EMBASE, PsycINFO, CINAHL and Web of Science were searched up to 25 May 2016. The 
search strategy included search terms relating to the population (smokers, mental health or 
substance use inpatients or prisoners), intervention (smoking cessation), outcome (relapse, 
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maintenance) and study types (cohort studies, clinical trials). Searches were limited to studies in 
English and adults. A full search strategy is in the online supplement (A1). Endnote X7 was used to 
record publications at all stages of the selection process. One reviewer (ES) screened all titles and 
abstracts of studies. Full text screening was undertaken by three authors; two reviewers (ES and 
LB) independently screened all papers and disagreements were settled by a third reviewer 
(AMcN); Kappa was calculated as a measure of agreement.  
Data extraction 
Using a pre-defined table, relevant data were extracted from all included studies by one reviewer 
and checked by a second reviewer. 
Assessment of risk of bias 
Risk of bias (study quality) was assessed independently by two reviewers using the Effective Public 
Health Practice Project tool (EPHPP). The tool has been designed to assess different study designs 
including randomised controlled trials and cohort studies. It consists of six sections: a) selection 
bias, b) study design, c) confounders, d) blinding, e) data collection method, f) withdrawals and 
dropouts; each section is rated as strong, moderate or weak. A study is rated as overall of strong 
quality if no section has been rated weak, moderate if one section is rated weak, and weak if two 
or more sections have been rated weak (Armijo-Olivo et al., 2012). Differences in assessment were 
discussed to arrive at an agreed assessment.  
Data synthesis 
For trials, two pre-specified Mantel-Haenszel random effects meta-analyses were conducted using 
RevMan 5.3 (Higgins and Green, 2011). The strongest available outcomes were used. For both 
analyses, those lost to follow-up were treated as non-abstinent with the exception of nine 
deceased participants (West et al., 2005). Subgroup analyses by setting (prison, substance abuse, 
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mental health) were planned. Observational studies were summarised in a narrative synthesis. 
Intervention components were coded using the Behaviour Change Technique (BCT) taxonomy 
(Michie et al., 2015) which defines 93 behaviour change techniques organised into 16 clusters 
Authors of eight studies were contacted for treatment manuals or treatment protocols as 
evidence indicates that descriptions in published papers are less comprehensive (Lorencatto et al., 
2013); authors for the remaining two studies could not be contacted (Jonas and Eagle, 1991, 
Joseph, 1993). A manual used in one trial (Clarke et al., 2013), a manual used in two trials 
(Hickman et al., 2015, Prochaska et al., 2014) and detailed descriptions for another trial (Stockings 
et al., 2014b) and two cohort studies (Strong et al., 2012, Stuyt, 2015) were provided; 
interventions in the other four studies were coded based on descriptions in the published papers. 
It was explored whether any link between behaviour change techniques used and outcomes of 
interventions could be hypothesised.  
 
RESULTS 
Description of studies 
The search identified 8,417 records; ten studies with a total N=1302 were included in the review 
(Figure 1). Eight studies had been selected by both initial reviewers; kappa was 0.71.  
Five studies (Clarke et al., 2013, Gariti et al., 2002, Hickman et al., 2015, Prochaska et al., 2014, 
Stockings et al., 2014b) were trials (intervention n=416, control n=415), five (Jonas and Eagle, 
1991, Joseph, 1993, Prochaska et al., 2006, Strong et al., 2012, Stuyt, 2015) were observational 
cohort studies (n=471). One study was conducted in Australia (Stockings et al., 2014b), all others in 
the US. One trial was conducted in a prison (Clarke et al., 2013), one trial and one cohort study in 
substance use treatment settings (Gariti et al., 2002, Joseph, 1993), two trials and three cohort 
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studies in mental health treatment settings (Hickman et al., 2015, Jonas and Eagle, 1991, 
Prochaska et al., 2006, Prochaska et al., 2014, Strong et al., 2012) and one trial and one cohort 
study in mixed substance use and mental health settings (Stockings et al., 2014b, Stuyt, 2015).  
All institutions were described as having complete smoke-free policies and the average length of 
stay in the smoke-free environment differed considerably; it was 1.5 years in the prison setting 
(Clarke et al., 2013), while all other studies measured the stay in days and the next longest was 90 
days (Stuyt, 2015). Follow-up periods ranged from 3 months (Clarke et al., 2013) to 18 months 
(Prochaska et al., 2014) (Table 1). All randomised trials (Clarke et al., 2013, Gariti et al., 2002, 
Hickman et al., 2015, Prochaska et al., 2014, Stockings et al., 2014b) and two of the observational 
cohort studies (Prochaska et al., 2006, Strong et al., 2012) used biochemically verified measures of 
seven-day point-prevalence smoking abstinence; the other three used self-reported abstinence 
(Jonas and Eagle, 1991, Joseph, 1993, Stuyt, 2015); only one trial reported continuous as well as 
point-prevalence abstinence (Stockings et al., 2014b). 
Reporting of effects of smoking cessation treatment or continued abstinence from smoking on 
mental health or substance use varied considerably across studies (Table 2). One trial found 
rehospitalisation to be less common in the intervention group (Prochaska et al., 2014) and one 
cohort study found non-smokers to be less likely to relapse to other substances (Stuyt, 2015). 
Intervention characteristics 
Interventions used a number of theoretical approaches, and varied in intensity, content and mode 
of delivery (Table 1). In all but one trial (Gariti et al., 2002), inpatient interventions were delivered 
by researchers, not clinic staff, whereas cohort studies generally reported on interventions 
delivered by clinic staff (with the exception of Strong et al., 2012)  
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Post-discharge interventions were included in the five trials (Clarke et al., 2013, Gariti et al., 2002, 
Hickman et al., 2015, Prochaska et al., 2014, Stockings et al., 2014b) and in one observational 
cohort study (Strong et al., 2012). Telephone calls were used in three studies (Clarke et al., 2013, 
Stockings et al., 2014b, Strong et al., 2012), ranging from one to eight calls between one day and 
four months post-discharge; two studies used a computer-generated intervention three and six 
months post-discharge (Hickman et al., 2015, Prochaska et al., 2014) and two provided an optional 
face-to-face appointment (Gariti et al., 2002, Stockings et al., 2014b) (one (Stockings et al., 2014b) 
in addition to telephone support). 
The trials used different control interventions that included treatment as usual (Gariti et al., 2002, 
Prochaska et al., 2014, Stockings et al., 2014b), enhanced treatment as usual (Hickman et al., 
2015) and a health-related intervention matched for frequency and duration but not addressing 
smoking cessation (Clarke et al., 2013).  
Risk of bias  
Four of the trials achieved a global rating of strong (Clarke et al., 2011, Hickman et al., 2015, 
Prochaska et al., 2014, Stockings et al., 2014b); one was rated moderate due to a risk of selection 
bias (Gariti et al., 2002). One observational cohort study was rated strong (Prochaska et al., 2006) 
the others were moderate or weak (Table 3).   
Effects of interventions 
Biochemically verified smoking abstinence  
Continuous abstinence was reported in only one study (Stockings et al., 2014b) at six months, two 
participants (1.9%) in the intervention group remained abstinent compared with none in the 
control group. Due to this lack of data, the primary outcome was not assessed in a meta-analysis. 
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The meta-analysis of seven-day point-prevalence abstinence at longest follow-up (3 to 18 months) 
included all five trials and found an overall effect in favour of intervention (RR=2.06, 95% CI: 1.30 
to 3.27, Figure 2a). Overall, 12.7% of participants in the intervention groups achieved abstinence 
compared with 5.8% in the control groups.  
The meta-analysis of seven-day point-prevalence abstinence at six months follow-up excluded the 
single trial conducted in a prison setting (longest follow-up was 3 months). The meta-analysis also 
found an effect in favour of intervention (RR=1.86, 95% CI: 1.04 to 3.31, Figure 2b); 10.5% and 
5.5% respectively achieved abstinence. No heterogeneity was indicated for either meta-analysis. 
No further subgroup analysis by setting was conducted because only one trial was set exclusively 
in substance use (Gariti et al., 2002) and one trial was set in both mental health and substance use 
settings (Stockings et al., 2014b). 
Two observational cohort studies (Prochaska et al., 2006, Strong et al., 2012) aimed to use 
biochemically verified 7-day point prevalence abstinence. However, in one all patients reported 
smoking at the 3-month follow-up (Prochaska et al., 2006), the other was a pilot study for 
intervention development and did not report results on verified abstinence (Strong et al., 2012).   
Self-reported smoking abstinence 
Four cohort studies reported self-reported abstinence without biochemical verification (Jonas and 
Eagle, 1991, Joseph, 1993, Strong et al., 2012, Stuyt, 2015). In one, four out of 39 psychiatric 
patients (10.3%) reported abstinence at 8 weeks post-discharge (Jonas and Eagle, 1991). In 
another study, 8.0% of patients admitted after the introduction of the smoke-free policy reported 
having quit smoking compared with 3.2% of patients admitted before introduction of the policy; 
however, length of follow-up differed, mean follow-up was 16 months for pre-policy and 11 
months for post-policy patients (Joseph, 1993). In a pilot with 15 participants, six participants 
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reported a quit attempt with a median number of 62 abstinent days (range 2 to 110 days) (Strong 
et al., 2012). A year after completing a 90-day substance misuse programme, an increase from 
14% to 27% non-smokers among 140 patients was reported (Stuyt, 2015). 
Other smoking outcomes – time to first cigarette 
Time to first cigarette post-discharge was assessed in two trials and two cohort studies (Clarke et 
al., 2013, Gariti et al., 2002, Jonas and Eagle, 1991, Prochaska et al., 2006). One trial and one 
cohort study reported that 76% of participants returned to smoking on the day of discharge (Gariti 
et al., 2002, Prochaska et al., 2006) and in another cohort study 72% of participants resumed 
smoking “immediately after discharge”(Jonas and Eagle, 1991). In the trial, 93% returned to 
smoking within a month with no group differences in the mean number of non-smoking days after 
discharge (Gariti et al., 2002). In one cohort study, median time to first cigarette was 5 minutes 
and all participants returned to smoking within 36 days (Prochaska et al., 2006), and in another, all 
participants who resumed smoking did so within eight weeks post-discharge (Jonas and Eagle, 
1991). The other trial displayed information graphically indicating that over 70% in the control 
group and about 50% in the intervention group returned to smoking within one day; this study 
reported an effect of treatment in a survival model of days to first smoking lapse (hazard 
ratio=1.75, p=0.001) (Clarke et al., 2013).  
Other smoking outcomes – change in cigarette consumption 
Change in cigarette consumption post-discharge compared with the period prior to the stay in a 
smoke-free environment was assessed in two trials and three cohort studies (Gariti et al., 2002, 
Jonas and Eagle, 1991, Joseph, 1993, Stockings et al., 2014b, Strong et al., 2012). One trial found a 
significant reduction for both groups for the six months following hospitalization (24.6 reduced to 
10.1 cigarettes per day for the intervention group and 23.8 to 9.4 cigarettes per day for the control 
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group, F(1)=21.07, p<0.001), with no group differences; self-reported reduction was supported by 
biochemical test results (Gariti et al., 2002). The other trial found a significant effect of the 
intervention for 50% reduction in cigarettes per day, with 36.5% of intervention participants 
having reduced their cigarette consumption by six months versus 8.9% in the control group 
(p<0.0001) (Stockings et al., 2014b). One cohort study reported a self-reported average decrease 
of seven cigarettes per day (95% CI: -13.80 to 0.51) with a group mean of 13 cigarettes at six-
month follow-up (SD=8.35, IQR: 8.2 to 16.1) (Strong et al., 2012). Another cohort study did not 
find any difference between self-reported number of cigarettes smoked per day at admission and 
six to 18 months post-discharge (21.6 (SD=13.6) vs 21.3 (SD=15.4) (Jonas and Eagle, 1991)). The 
third cohort study stated that around 20% of patients reported smoking less (without 
quantification) and no difference between patients treated before and after the introduction of a 
smoke-free policy (Joseph, 1993). 
Behaviour change techniques  
The number of BCTs that could be coded varied considerably between studies and was higher 
when manuals were available. It ranged from a single technique in published reports of two cohort 
studies (Jonas and Eagle, 1991, Prochaska et al., 2006) to 34 BCTs (Clarke et al., 2013) and 36 BCTs 
(Hickman et al., 2015, Prochaska et al., 2014) in trial manuals (Table 1).  
All studies delivered at least one BCT from the ‘Regulation’ cluster. This cluster includes 
pharmacological support, reducing negative emotions, conserving mental resources and 
paradoxical instructions (the latter was not delivered in any study). No study included BCTs coded 
to be part of the ‘Scheduled consequences’ cluster, which includes ten BCTs focused on specific 
reward or punishment schedules (other incentives or rewards are included in a different cluster). 
Two trials covered all remaining 15 clusters (Hickman et al., 2015, Prochaska et al., 2014); the trial 
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(Clarke et al., 2013) with the next highest number of BCTs covered 14 clusters, additionally 
omitting ‘Comparison of behaviour’.  
The most commonly used technique was pharmacological support (n=9). Pharmacological support 
in the form of nicotine replacement therapy (NRT) was used in four of the five trials (Gariti et al., 
2002, Hickman et al., 2015, Prochaska et al., 2014, Stockings et al., 2014b), mostly in the form of 
patches, and this was available both during and after the stay in the smoke-free institution. In four 
of the five observational cohort studies (Jonas and Eagle, 1991, Prochaska et al., 2006, Strong et 
al., 2012, Stuyt, 2015), NRT was available only during inpatient treatment. One study mentioned 
availability of clonidine patches as part of treatment as usual (Joseph, 1993). The next most 
commonly used BCTs (all n=6, Table 2) were problem solving (‘Goals and planning’ cluster), 
unspecified social support (‘Social support’ cluster) and pros and cons (‘Comparison of outcomes’ 
cluster).  
Generally, studies delivered fewer BCTs post-discharge than during the stay, with the exception of 
one trial (Stockings et al., 2014b), which delivered a more comprehensive intervention after 
patients had left the hospital.    
In addition to the BCTs described in the interventions, a smoke-free environment in itself delivers 
a number of BCTs for smoking cessation such as restructuring the physical environment (BCT 12.1), 
restructuring the social environment (12.2), avoidance/reducing exposure to cues for the 
behaviour (12.3) and removing access to the reward (7.4) (Michie et al., 2015).  
Due to the small number of studies, variable study designs and inconsistent outcome measures, 
associations between specific behaviour change techniques and outcomes could not be assessed 
statistically. The two trials reporting an overall positive effect (Clarke et al., 2013, Prochaska et al., 
2014) differed in setting, length of stay, mode and intensity of intervention and length of follow-
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up, but both used over 30 behaviour change techniques during the stay. Interestingly, one did not 
include pharmacotherapy (Clarke et al., 2013), while the second did during the stay and post-
discharge (Prochaska et al., 2014). However, another trial using the same techniques as Prochaska 
et al., 2014 in a smaller sample from a similar population detected no effect (Hickman et al., 
2015).  
DISCUSSION 
A systematic search found only ten small studies researching maintenance of abstinence from 
smoking after a period of enforced abstinence in populations with high mental health comorbidity. 
Outside of trial intervention groups, no or minimal support for maintaining abstinence was 
delivered. Relapse to smoking occurred very quickly following discharge, and the four studies that 
reported it found that at least 70% of participants relapsed to smoking on the day of discharge. 
There was some evidence that providing behavioural or pharmacological interventions was 
effective for improving abstinence. 
Evidence on how best to maintain or increase abstinence in this setting remains limited with few 
trials or high-quality observational studies. The trials mostly had a low risk of bias while the cohort 
studies by design were more likely to be affected by bias. In terms of outcome measures, although 
most used biochemical validation, few attempted to measure continuous abstinence, the 
strongest outcome (West et al., 2005). However, in this population and setting, a floor effect for 
continuous abstinence at follow-up would be likely. A single study evaluated an intervention in a 
prison setting. There was little variety in location; all but one study had been conducted in the US. 
The interventions under study varied, but many evidence-based interventions have not been 
evaluated. For example, there is good evidence that contingency management is effective for 
increasing abstinence from smoking, although there is limited evidence in smokers with mental 
health problems (Cahill et al., 2015, Hunt et al., 2013). Pharmacotherapies were also limited and 
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no study tested varenicline (Cahill et al., 2016) cytisine (Cahill et al., 2016) or bupropion (Hughes et 
al., 2014, Tsoi et al., 2013, van der Meer et al., 2013) which have all shown effectiveness. 
Limitations of the review include that policies such as smoke-free institutions may be 
implemented without an evaluation of the effects in the peer-reviewed literature. However, we 
searched Web of Science, one source of grey literature. Another limitation is due to the 
complexity and reliability of coding BCTs (Abraham et al., 2015), more experienced coders may 
have coded some aspects differently. However, the included analysis of BCTs for the first time 
provides evidence on components assessed in studies to date.  
In contrast to the one previous review of the impact of smoke-free psychiatric hospitalisation on 
smoking (Stockings et al., 2014a), the present review includes only longitudinal studies and 
includes non-psychiatric institutions with high prevalence of mental health problems. Additionally, 
in our review, smokers were exposed to complete smoke-free policies and received some 
intervention to support abstinence. The previous review findings suggested these are crucial for a 
stay in a smoke-free institution to have an effect on smoking (Stockings et al., 2014a).     
As in previous reports (Lorencatto et al., 2013), we found some large differences between 
descriptions of behavioural interventions in some published reports and manuals. Most strikingly, 
coding from the manual instead of the publication increased the number of BCTs from four 
(Hickman et al., 2015, Prochaska et al., 2014) to over 30 each in two cases. Due to the small 
number of studies and their variable study designs and outcome measures, it remains difficult to 
draw any clear conclusions about associations between specific techniques and effects of the 
intervention.  
The present evidence suggests that a larger number of BCTs from a wide range of clusters is more 
likely to result in an effective intervention. It is worth noting that even where the same BCTs are 
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included, delivery will differ (Lorencatto et al., 2016, Lorencatto et al., 2014, Tate et al., 2016), e.g. 
in frequency, quality and fidelity which can impact effects, akin to medication effectiveness 
depending on the amount and duration of, and adherence to, treatment. 
The present review focused on mental health; it is likely that interventions in other setting such as 
general hospitals would be transferrable to some extent. However, an existing Cochrane review 
covered these institutions (Rigotti et al., 2012) while excluding institutions that primarily treat 
mental health problems or substance abuse. That review found evidence that interventions of the 
highest intensity, consisting of counselling that began in the hospital and continued for more than 
one month post-discharge, increased smoking cessation post-discharge; no benefit could be 
detected from the large number of studies with less intense interventions. The review also found 
that addition of NRT conferred a benefit while there was not enough evidence for clear 
conclusions on varenicline or bupropion when added to counselling (Rigotti et al., 2012). For the 
present review, not enough studies were available to distinguish the impact of interventions 
delivered during the stay and post-discharge.  
Reviews evaluating the evidence for preventing relapse for smokers in the general population who 
have successfully quit for a short time found some evidence for the use of NRT, bupropion or 
varenicline (Agboola et al., 2010) but insufficient evidence to recommend the use of any specific 
behavioural intervention (Agboola et al., 2010, Hajek et al., 2013), indicating the general scarcity 
of evidence on maintaining abstinence in any population of smokers. 
Future research should evaluate interventions in more diverse countries, policy settings and 
institutions that enforce abstinence as e.g. evidence for prisons is particularly lacking. Research on 
the effectiveness of interventions such as contingency management and pharmacotherapies other 
than NRT would be beneficial. Improved reporting is recommended; more comprehensive 
descriptions of interventions, potentially using frameworks such as the behaviour change 
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technique taxonomy (Michie et al., 2015) would facilitate replication of studies and analysis of 
effectiveness of different intervention components. In addition, it would be beneficial to report 
clearly and comprehensively any effects of cessation treatment or cessation on mental health and 
substance use.  
Conclusion 
In populations with high rates of smoking and mental health comorbidity there is rapid and almost 
complete relapse to smoking after a period of enforced abstinence. Institutions implementing 
smoke-free policies need to also implement interventions to support sustained abstinence to help 
reduce inequalities in morbidity and mortality due to smoking. Interventions consisting of nicotine 
replacement and/or behavioural support can increase abstinence beyond discharge. However, the 
existing evidence base is small, tested only a narrow range of interventions and is limited by 
imprecise reporting of behavioural interventions. Pharmacological interventions other than NRT 
and additional behavioural interventions should be assessed and reported. 
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Table 1. Study description 
Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
RANDOMISED CONTROLLED TRIALS    
Clarke et al., 
JAMA Intern 
Med., 2013a  
(study 
protocol 
(Clarke et al., 
2011)) 
Prison, US, 
n=247 
Length of stay: 
Measured as time since last 
cigarette smoked, M (SD) = 1.5 (3.4) 
years 
Inpatient:  
6 sessions, sessions 1 and 6 based 
on Motivational Interviewing, 
sessions 2 to 5 based on CBT, 
delivered by Research Assistants, 
one-to-one. 
Post-discharge:  
Telephone calls 24 hours and 7 days 
post-discharge 
1.1 Goal setting (behaviour) 
1.2 Problem solving 
1.4 Action planning 
2.3 Self-monitoring of behaviour 
3.1 Social support (unspecified) 
3.3 Social support (emotional) 
4.1 Instruction on how to perform a behaviour 
4.2 Information about antecedents 
5.1 Information about health consequences 
5.4 Monitoring of emotional consequences 
5.6 Information about emotional consequences 
7.4 Remove access to the reward 
8.1 Behavioural practice/rehearsal 
8.2 Behaviour substitution 
8.3 Habit formation 
1.5 Review behaviour goal(s) 
1.7 Review outcome goal(s) 
3.1 Social support (unspecified) 
10.4 Social reward 
 
Inpatient:  
Videos on health-related 
topics but not about smoking 
cessation. 
Post-discharge:  
Telephone calls 24 hours and 
7 days post-discharge. 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
8.4 Habit reversal 
9.2 Pros and cons 
9.3 Comparative imagining of future outcomes 
11.2 Reduce negative emotions 
11.3 Conserving mental resources 
12.1 Restructuring the physical environment 
12.2 Restructuring the social environment 
12.3 Avoidance/reducing exposure to cues for the 
behaviour 
12.6 Body changes 
13.2 Framing/reframing 
13.4 Valued self-identity 
13.5 Identity associated with changed behaviour 
15.2 Mental rehearsal of successful performance 
15.3 Focus on past success 
15.4 Self-talk 
16.2 Imaginary reward 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
 
Gariti et al., 
Am J Drug 
Alcohol 
Abuse, 2002  
Veterans 
Affairs 
Medical 
Center’s 
detoxification 
unit for 
alcohol and 
other non-
nicotine 
drugs, US, 
n=62 
Length of stay: 
M = 7.4 days. 
Inpatient:  
One manual-based individual 
session delivered by Addiction 
Therapist, one-to-one. Participants 
encouraged to attend daily film 
series, Motivational enhancement 
(MET) post-film discussion in group. 
Post-discharge:  
Optional smoking cessation 
program delivered face-to-face by 
study co-investigator or nurse 
practitioner   
  
3.1 Social support (unspecified) 
5.3 Information about social and environmental 
consequences 
6.1 Demonstration of the behaviour 
9.2 Pros and cons 
11.1 Pharmacological support (nicotine patch 
3.1 Social support (unspecified) 
11.1 Pharmacological support 
(nicotine patch) 
Inpatient and post-discharge:  
3.1 Social support 
(unspecified) 
11.1 Pharmacological support 
(nicotine patch) 
Optional smoking cessation 
program delivered face-to-
face by study co-investigator 
or nurse practitioner   
 
Hickman et Three Length of stay: 1.1 Goal setting (behaviour) 11.1 Pharmacological support Inpatient:  
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
al., Nicotine 
Tob Res, 
2015a  
psychiatric 
units (one 
non-acute 
and two 
acute units) 
in public 
acute care 
hospital, US, 
n=100 (3 
deaths during 
follow-up) 
47% stayed 2-7 days, 30% 8-13 
days, 23% 2 weeks or longer 
Inpatient:  
Transtheoretical model-tailored 
computer-delivered intervention, 
self-help information, 15–30 minute 
on-unit individual motivational 
enhancement cessation counselling, 
delivered by study staff 
Post-discharge:  
Computer intervention repeated at 
3 and 6 months, optional NRT for 
up to 10 weeks 
1.2 Problem solving 
1.4 Action planning 
1.9 Commitment 
2.4 Self-monitoring of outcome(s) of behaviour 
3.1 Social support (unspecified) 
3.3 Social support (emotional) 
4.2 Information about antecedents 
5.1 Information about health consequences 
5.3 Information about social and environmental 
consequences 
5.6 Information about emotional consequences 
6.2 Social comparison 
6.3 Information about others’ approval 
7.1 Prompts/cues 
8.1 Behavioural practice/rehearsal 
8.2 Behaviour substitution 
8.7 Graded tasks 
(NRT) 3.1 Social support 
(unspecified) 
11.1 Pharmacological support 
(NRT) 
Delivered by study staff 
Post-discharge:  
Referrals (without NRT) 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
9.2 Pros and cons 
9.3 Comparative imagining of future outcomes 
10.3 Non-specific reward 
10.4 Social reward 
10.9 Self-reward 
11.1 Pharmacological support (NRT) 
11.2 Reduce negative emotions 
12.1 Restructuring the physical environment 
12.2 Restructuring the social environment 
12.3 Avoidance/reducing exposure to cues for the 
behaviour 
12.4 Distraction 
12.5 Adding objects to the environment 
12.6 Body changes 
13.2 Framing/reframing 
13.5 Identity associated with changed behaviour 
15.2 Mental rehearsal of successful performance 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
15.3 Focus on past success 
15.4 Self-talk 
16.2 Imaginary reward 
 
Prochaska 
et al., Am J 
Public 
Health, 
2014a  
Locked 
inpatient 
psychiatry 
unit at the 
Psychiatric 
Institute, US, 
n=224 (4 
deaths during 
follow-up) 
Length of stay: 
M (SD) = 7.4 (5.7) days, median = 
6.0, mode = 5 
Inpatient:  
Transtheoretical model-tailored 
computer-delivered intervention, 
15–30 minute on-unit individual 
motivational enhancement 
cessation counselling, delivered by 
study staff 
Post-discharge:  
Computer intervention repeated at 
3 and 6 months, optional NRT for 
1.1 Goal setting (behaviour) 
1.2 Problem solving 
1.4 Action planning 
1.9 Commitment 
2.4 Self-monitoring of outcome(s) of behaviour 
3.1 Social support (unspecified) 
3.3 Social support (emotional) 
4.2 Information about antecedents 
5.1 Information about health consequences 
5.3 Information about social and environmental 
consequences 
5.6 Information about emotional consequences 
6.2 Social comparison 
11.1 Pharmacological support 
(nicotine patches) 
Inpatient:  
11.1 Pharmacological support 
(nicotine patches) 
Post-discharge:  
No intervention 
 
  29 
 
Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
up to 10 weeks 6.3 Information about others’ approval 
7.1 Prompts/cues 
8.1 Behavioural practice/rehearsal 
8.2 Behaviour substitution 
8.7 Graded tasks 
9.2 Pros and cons 
9.3 Comparative imagining of future outcomes 
10.3 Non-specific reward 
10.4 Social reward 
10.9 Self-reward 
11.1 Pharmacological support (NRT) 
11.2 Reduce negative emotions 
12.1 Restructuring the physical environment 
12.2 Restructuring the social environment 
12.3 Avoidance/reducing exposure to cues for the 
behaviour 
12.4 Distraction 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
12.5 Adding objects to the environment 
12.6 Body changes 
13.2 Framing/reframing 
13.5 Identity associated with changed behaviour 
15.2 Mental rehearsal of successful performance 
15.3 Focus on past success 
15.4 Self-talk 
16.2 Imaginary reward 
 
Stockings et 
al., 2014a 
(study 
protocol 
Stockings et 
al., 2011) 
One 
comorbid 
acute mental 
health and 
substance 
use unit and 
two acute 
mental 
Length of stay: 
M (SD) = 22.6 (78.0) days 
Inpatient:  
Self-help smoking cessation 
literature, 10-15 minutes face-to-
face motivational interview, 
delivered by study staff   
 
3.1 Social support (unspecified) 
5.1 Information about health consequences 
5.3 Information about social and environmental 
consequences 
5.6 Information about emotional consequences 
9.2 Pros and cons 
9.3 Comparative imagining of future outcomes 
11.1 Pharmacological support (NRT) 
1.2 Problem solving 
2.1 Monitoring of behaviour 
without feedback 
2.3 Self-monitoring of 
behaviour 
3.1 Social support (unspecified) 
4.1 Instruction on how to 
perform a behaviour 
Inpatient:  
3.1 Social support 
(unspecified) 
11.1 Pharmacological support 
(NRT) 
Delivered by clinic staff 
Post-discharge:  
11.1 Pharmacological support 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
health units  
in public 
hospital, 
Australia, 
n=205 
Post-discharge:  
4 months of fortnightly telephone 
smoking cessation support with a 
designated counsellor, optional 12-
week NRT (choice of patches, gums, 
lozenges, and inhalers), optional 
referrals to Quitline or smoking 
cessation groups 
4.3 Re-attribution 
5.1 Information about health 
consequences 
5.3 Information about social 
and environmental 
consequences 
5.4 Monitoring of emotional 
consequences 
7.1 Prompts/cues 
8.2 Behaviour substitution 
10.4 Social reward 
11.1 Pharmacological support 
(NRT) 
12.2 Restructuring the social 
environment 
12.3 Avoidance/reducing 
exposure to cues for the 
(NRT, for three days upon 
discharge) 
Post-discharge smoking care 
plan and optional referral to 
Quitline 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
behaviour 
12.4 Distraction 
12.5 Adding objects to the 
environment 
 
COHORT STUDIES     
Jonas & 
Eagle, 1991 
Short-term 
psychiatric 
unit of a 
general 
hospital, US, 
n=39 
Length of stay: 
M (SD) = 14.1 (7.0) days 
Inpatient:  
Nicotine gum and education in its 
use, self-help materials about 
smoking cessation, delivered by 
nursing staff 
Post-discharge: 
None 
11.1 Pharmacological support (NRT, gum)   
Joseph, 
1993  
21-day 
residential 
Length of stay: 
Not reported; 21-day inpatient 
1.1 Goal setting (behaviour) 
1.8 Behavioural contract 
n/a n/a 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
drug 
dependency 
treatment 
program, US, 
n=163 
 
program 
Inpatient:  
Written agreement to adhere to 
new smoke-free policy, arranged by 
clinic staff 
Post-discharge:  
None  
11.1 Pharmacological support (clonidine) 
Prochaska 
et al., 2006  
University- 
based adult 
inpatient 
psychiatry 
unit, US, 
n=100 
Length of stay: 
M (SD) = 6.4 (5.5) days, range = 1-
37. 
Inpatient:  
Clinic staff provided treatment as 
usual 
Post-discharge:  
Occasionally NRT as part of 
treatment as usual 
 
11.1 Pharmacological support (NRT patch and/or 
gum) 
11.1 Pharmacological support 
(NRT) 
n/a 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
Strong et al., 
2012a  
Two 
inpatient 
units in a 
psychiatric 
hospital, US, 
n=15 
Length of stay: 
M (SD): 7.2 (2.6) days 
Inpatient:  
One face-to-face 45 minute 
Motivational Interviewing session, 
delivered by study staff, 
information on quitlines and 
treatment  
Post-discharge:  
Phone call 2 weeks post-discharge 
 
1.4 Action planning 
2.1 Monitoring of behaviour without feedback 
2.2 Feedback on behaviour 
8.2 Behaviour substitution 
9.2 Pros and cons 
11.1 Pharmacological support (NRT) 
13.3 Incompatible beliefs 
13.4 Valued self-identity 
1.2 Problem solving 
1.4 Action planning 
1.5 Review behaviour goal(s) 
3.1 Social support (unspecified) 
10.3 Non-specific reward 
Inpatient:  
11.1 Pharmacological support 
(NRT) 
Post-discharge:  
No intervention 
 
 
Stuyt, 2015a  90-day 
inpatient 
treatment 
program for 
co-occurring 
substance 
Length of stay: 
Not reported; 90-day inpatient 
program. 
Inpatient:  
Tobacco topic is fully integrated 
into the program, delivered by 
1.2 Problem solving 
2.5 Monitoring outcome(s) of behaviour by others 
without feedback 
2.6 Biofeedback 
4.1 Instruction on how to perform a behaviour 
5.1 Information about health consequences 
n/a n/a 
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Authors, 
publication 
details 
Setting, 
country, n 
Length of stay, intervention 
format, provider, mode 
Inpatient intervention behaviour change 
techniques b, c (Michie et al., 2015) 
Post-discharge behaviour 
change techniques c 
Control 
abuse and 
mental 
health 
problems, 
US, n=154 (4 
deaths during 
follow-up) 
centre staff, one-to-one and groups 
Post-discharge:  
None described 
5.3 Information about social and environmental 
consequences 
5.6 Information about emotional consequences 
11.1 Pharmacological support (Nicotine patch) 
Abbreviations: n = Number of participants, NRT = Nicotine Replacement Therapy; US = United States 
a Study author(s) provided additional information about study interventions in the form of intervention manuals or similar documents. 
b In addition to the Behaviour Change Techniques (BCTs) described in the interventions, a smoke-free environment in itself delivers a number of BCTs for smoking cessation. These include 
restructuring the physical environment (BCT 12.1), restructuring the social environment (12.2), avoidance/reducing exposure to cues for the behaviour (12.3) and removing access to the 
reward (7.4). (Michie et al., 2015)  
c Number indicates position in clusters; cluster labels are: 1: ‘Goals and planning’, 2 ‘Feedback and monitoring’, 3 ‘Social support’, 4 ‘Shaping knowledge’, 5 ‘Natural consequences’, 6 
‘Comparison of behaviour’, 7 ‘Associations’, 8 ‘Repetition and substitution’, 8 ‘Comparison of outcomes’, 10 ‘Reward and threat’, 11 ‘Regulation’, 12 ‘Antecedents’, 13 ‘Identity’, 14 
‘Scheduled consequences’, 15 ‘Self-belief’, 16 ‘Covert learning’. 
d Italics: Behaviour change techniques used in intervention but not in control.  
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Table 2 Outcomes of included studies; N = 10. 
Study Key smoking outcome measures, follow-ups, findings Variables associated with smoking outcomes Mental health and other substance use outcomes 
RANDOMISED CONTROLLED TRIALS   
Clarke et 
al., 2013 
Measures 
Self-reported 7-day smoking abstinence verified by urine 
cotinine level <200 ng/mL; 
Nicotine dependence (FTND); 
Time to first cigarette after release 
Follow-up 
3 weeks and 3 months for those abstinent at 3 weeks 
Findings 
Abstinence:   
- 3-weeks: AOR = 6.6, 95% CI: 2.5-17.0 for intervention 
- 3-months: AOR = 5.3, 95% CI: 1.4-23.8 for intervention 
Time to first cigarette (3 week follow-up): Treatment  main 
effect: β(SE) = 0.56 (0.16), hazard ratio = 1.75 (p=.001) 
 
Associated with abstinence at 3-week follow-up 
Not smoked for >6 months (baseline): AOR=4.6, 95% 
CI: 1.7-12.4; 
Hispanic: AOR=3.2, 95% CI: 1.1-8.7; 
Planned not to smoke after release (baseline): 
AOR=1.6, 95% CI: 1.2-2.3 
 
At 3-week follow-up: 
Perceived stress (PSS)M (SD) 21.5 (6.1) non-smoker 
vs 21.9 (6.3) smoker (non-significant); 
Depression (CES-D) M (SD) : 12.3 (4.9) non-smoker vs 
12.8 (5.5) smoker (non-significant) 
Gariti et al, 
2002 
Measures 
Self-reported 7-day smoking abstinence verified by CO 
reading ≤ 9 parts per million and urine cotinine level 
None reported 
 
Almost 47% of participants were abstinent for their 
primary drug of abuse at the follow up; 
No differences between groups 
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<50 ng/mL; 
Time to relapse after discharge; 
Cigarettes per day 
Follow up 
6 months 
Findings 
Abstinence: 6% of intervention vs 0% of control 
(2 (1) = 0.002, p = .97); 
Time to first cigarette: 76% reported smoking the same day 
they were discharged, 92.7% smoked within a month of 
discharge, no differences between groups in the mean 
number of days before relapse, t(52)=0.65, p=.52; 
Cigarettes per day: Reduced for both groups F(1) = 21.1, 
p<.001; no differences between groups  
 
Hickman et 
al., 2015 
Measures 
Self-reported 7-day smoking abstinence verified by CO 
reading ≤ 10 parts per million or a confirmation of 
participant’s past 7 days non-smoking status obtained from 
friends, family, or case managers if a participant was unable 
Associated with abstinence over 12-month study 
period 
Quitting over time: AOR = 1.16, 95% CI: 1.04-1.29; 
Higher social status in United States (baseline): 
AOR = 1.25, 95% CI: 1.04-1.50; 
Over the 12 months of follow-up, 55% of control and 
57% of intervention group participants were 
rehospitalised or seen by psychiatric emergency care 
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to attend in person 
Follow-up 
3, 6, and 12 months 
Findings 
Abstinence: 
- 3 months: 12.5% intervention vs 7.3% control 
- 6 months: 17.5% intervention vs 8.5% control 
- 12 months: 26.2% intervention vs 16.7% control 
Abstinence modelled over 12-month period: AOR = 1.76, 95% 
CI: 0.69-4.48 for intervention 
 
Stronger desire to quit (baseline): AOR = 1.28, 
95% CI: 1.06-1.55; 
Higher expectation of success with quitting (baseline: 
AOR = 1.26, 95% CI: 1.06-1.50 
 
Prochaska 
et al., 2014 
Measures 
Self-reported 7-day smoking abstinence verified by CO 
reading ≤ 10 parts per million or confirmation of participant’s 
past 7 days non-smoking status obtained from significant 
others if the participant was unable to attend in person 
Follow-up: 
3, 6, 12, and 18 months 
Findings 
Abstinence:  
Associated with abstinence over 18-month study 
period 
Higher expectation of success with quitting 
(baseline): AOR = 1.17, 95% CI: 1.06-1.31; 
Higher perceived difficulty with staying quit 
(baseline): AOR = 0.86, 95% CI: 0.76-0.97; 
Time to first cigarette < 30 min (baseline): 
AOR = 0.51, 95% CI: 0.26-0.96 
 
Over an 18-month study period, 56% of control and 
44% of intervention group participants were 
rehospitalised, t(223)=2.1, p=.036; this was predicted 
by: Usual care condition: AOR = 1.92, 95% CI: 1.06-
3.49; Psychotic symptoms (BASIS-24): AOR = 1.43, 
95% CI: 1.09-1.89; Unstable housing: AOR = 2.09, 
95% CI: 1.12-3.92; ≥8 previous psychiatric 
hospitalisations vs none: AOR = 3.21, 95% CI: 1.37-
7.54 
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- 3 months: 13.9% intervention vs 3.2% control 
-  6 months: 14.4% intervention vs 6.5% control 
- 12 months: 19.4% intervention vs 10.9% control 
- 18 months: 20.0% intervention vs 7.7% control 
Abstinence modelled over 18-month period: AOR = 3.85, 95% 
CI: 1.39-11.11 for intervention (reverse of AOR = 0.26, 95% 
CI: 0.09-0.72 reported by authors) 
 
Stockings et 
al., 2014 
Measures 
Self-reported continuous smoking abstinence verified by CO 
reading < 10 parts per million; 
Self-reported 7-day smoking abstinence verified by CO 
reading < 10 parts per million; 
≥50% reduction in cigarettes per day; 
Quit attempts after hospitalisation; 
Nicotine dependence (FTND) 
Follow-up 
1 week and 2, 4, and 6 months 
Findings  
Continuous abstinence: 
Use of NRT associated with point prevalence 
abstinence at 4 months (χ2(3) = 6.8, 
p=.009), no other significant associations 
Psychological distress (K10) over 6-month period:  
- Condition-by-time interaction: F(3,621)=1.48, p=.22 
- Main effect of condition: F(1,621)=.04, p=.85 
- Main effect of time: F(3,621)=63.2, p<.0001 
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- 1-week: 5.8% intervention vs 1% control (p=.06) 
- 2 months: 2.9% intervention vs 0% control (p=.13) 
- 4 months: 1.9% intervention vs 0% control (p=.26) 
- 6 months: 1.9% intervention vs 0% control (p=.26) 
Point prevalence abstinence (intervention vs control):   
- 1 week: OR=1.37, 95% CI: 0.45-4.98 
- 2 months: OR=2.27, 95% CI: 0.81-7.52 
- 4 months: OR=6.46, 95% CI: 1.50-32.77  
-  6 months: OR = 1.32, 95% CI: 0.47-4.36  
Quit attempts at 6-month follow-up: OR = 2.89, 95% CI: 1.43-
5.98 for intervention 
≥50% reduction in cigarettes per day at 6-month follow-up: 
OR = 5.90, 95% CI: 2.89-15.25 for intervention 
FTND over 6-month period:  
- Condition-by-time interaction: F(3,406)=8.5, p<.0001 
- Main effect of condition: F(1,215)=9.8, p=.002 
- Main effect of time: F(3,406)=10.9, p<.0001 
 
COHORT STUDIES   
Jonas & Measures Associated with abstinence at follow-up None reported 
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Eagle, 1991 Self-reported smoking abstinence; 
Cigarettes per day; 
Time to relapse after discharge 
Follow-up 
Varying from 6 to 18 months after discharge 
Findings 
Abstinence: 4/39 (10.3%) were non-smokers; 
Relapse: 28/35 (80%) relapsed immediately after discharge, 
3/35 (8.6%) within one week, 2/35 (5.7%) one to four weeks, 
and 2/35 (5.7%) relapsed one month post-discharge 
 
M (SD) cigarettes per day (baseline): 6.8 (5) non-
smokers vs 23.4 (13.5) smokers, t(34)  = 2.4, p<.02 
 
Joseph, 
1993 
Measures 
Self-reported smoking behaviour 
Follow-up 
On average 10.7 months post-discharge 
Findings 
Abstinence: 13/163 (8%) non-smokers after introduction of 
smoke-free policy vs 5/156 (3%) (p<.05) before smoke-free 
policy  
 
None reported Use of other substances at follow up: 145/163 (89% 
with smoke-free policy) vs 151/156 (97% pre-smoke-
free policy) reported improvement in chemical 
dependency (p=.15) 
  42 
 
Prochaska 
et al., 2006 
Measures 
Self-reported 7-day smoking abstinence verified by CO 
reading ≤ 10 parts per million; 
Nicotine dependence (FTND); 
Time to relapse post-discharge; 
Initiation of quit attempt post-relapse 
Follow-up 
1 week and 1 and 3 months post-discharge 
Findings 
Abstinence at 3 months: 4/100 (4%) were non-smokers, 
although had been relapsed after discharge 
Relapse: Ranged from seconds to 36 days, 76% reported 
smoking the same day they were discharged, with a median 
time to first cigarette of 5 minutes 
Quit attempts: 48% reported a 24-hour quit attempt after 
relapsing post-discharge 
Associated with abstinence at 3-month follow up: 
Less perceived difficulty with staying quit (baseline): 
F(1,97) = 4.16, p=.044 
Associated with relapse on the day of discharge vs 
later 
Heavier smoker (baseline): r=.18, p=.047; 
Higher FTND score: r=.19, p=.043; 
Stronger craving and urges to smoke during 
hospitalisation: r=.23, p=.014; 
Fewer lifetime quit attempts: r=-.19, p=.034; 
Fewer past year quit attempts: r=-.26, p=.008; 
Less desire for abstinence: r=-.29, p=.002; 
Lower expectation of success: r=-.32, p=.001; 
Pre-contemplation or contemplation vs preparation 
stage: 2(2) = 20.12, p<.001; 
Non-abstinence related goals: OR=.26, p=.016; 
Depressive disorder: OR=3.3, p=.030 
Associated with quit attempt initiation following 
relapse post-discharge 
Lower FTND score: r=-.22, p=.019; 
During the 3-month follow-up period, 81% of 
participants had a mental health contact, 1/3 of them 
were rehospitalised. Rehospitalisation was not 
related to quit attempts. 
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More past year quit attempts: r=.24, p=.018; 
Greater desire for abstinence: r=.26, p=.005; 
Greater expectation of success: r=.21, p=.025; 
Less perceived difficulty with staying quit (baseline): 
r=-.24, p=.013; 
Preparation stage: OR=5.7, p=.002; 
Goal of complete abstinence: OR=5.4, p=.003; 
NRT use post-discharge: OR=6.9, p<.001 
Not smoking on the day of discharge: OR=6.7, p=.001 
 
Strong et 
al., 2012 
Measures 
Self-reported 7-day smoking abstinence verified by CO 
reading < 8 parts per million; 
Quit attempt made and length of attempt; 
Cigarettes per day 
Follow-up 
6 months post-discharge 
Findings 
Abstinence: No one abstinent 
Quit attempt: 6/15 (40%) reported attempt with median 
None reported Depressive symptoms over 6-month period 
No significant change in PHQ-9 scores over time, 
β(SE) = 0.08 (0.09), p=.33, 
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length of 62 days, range: 2 to 110 days. 
Cigarettes per day: Average reduction of 7.16, t(10)=-2.4, 
p<.04 
Stuyt, 2015 Measures 
Self-reported tobacco abstinence in the past month verified 
by tissue testing results obtained from probation officers 
Follow-up 
Monthly for 12 months, only 12 months reported 
Findings 
Abstinence: 18/120 (15% of smokers at admission) were non-
smokers 
 
None reported Relapse to alcohol or drugs 
70/102 (69%) of smokers post-discharge vs 5/18 
(28%) of non-smokers post-discharge, 2 = 10.9, 
p=.001 
FTND: Fagerstrom Test of Nicotine Dependence; PSS: Perceived stress scale; CES-D: Centre for Epidemiologic Studies Depression Scale; PHQ-9: nine item depression screen 
from Patient Health Questionnaire. 
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Table 3. Risk of bias (study quality) assessment (Armijo-Olivo et al., 2012) 
 
Selection bias Design Confounders Blinding Data collection  
Withdrawals and  
drop-outs 
Global rating 
RANDOMISED CONTROLLED TRIALS        
Clarke et al, 2013  2 1 1 2 1 2 Strong 
Gariti et al, 2002  3 1 1 2 1 1 Moderate 
Hickman et al, 2015  2 1 1 2 1 1 Strong 
Prochaska et al, 2014  2 1 1 2 1 1 Strong 
Stockings et al, 2014  2 1 1 2 1 2 Strong 
COHORT STUDIES        
Jonas & Eagle, 1991 3 2 n/a 2 3 3 Weak 
Joseph, 1993 3 2 3 2 3 n/a Weak 
Prochaska et al, 2006  2 2 n/a 2 1 1 Strong 
Strong et al, 2012 3 3 n/a 2 1 n/a Weak 
Stuyt, 2015  1 2 n/a 2 3 1 Moderate 
Abbreviation: n/a: Assessment item not applicable for a particular study design 
Note: 1=strong, 2=moderate, 3=weak
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Figure 1. Study selection 
  
Records identified through database 
searching  
 
Records after duplicates removed  
(n = 5,622) 
Records excluded after titles and 
abstracts screening  
(n = 5,449) 
Full-text articles assessed for eligibility  
(n = 173) 
Full-text articles excluded, with reasons  
(n = 164) 
1. No enforced smoking abstinence 
(n = 132) 
2. Not a psychiatric institution, substance 
abuse treatment centre, or a prison 
(n = 22) 
3. No intervention to maintain smoking 
abstinence (n = 7) 
4. Not a longitudinal study (n = 3) 
Studies included from other sources  
(n = 1) 
Studies included in synthesis  
(n = 10) 
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Figure 2.  
a. Comparison of biochemically verified point-prevalence abstinence at longest follow-up in randomised trials. Note: 
Length of follow-up: Clarke 3 months, Gariti 6 months, Hickman 12 months, Prochaska 18 months, Stockings 6 
months.  
b. Comparison of biochemically verified point-prevalence abstinence at 6 month follow-up in randomised trials. 
Abbreviations: M-H=Mantel-Haenszel 
  
a. 
b. 
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Leonie S. Brose, Erikas Simonavicius & Ann McNeill. Maintaining abstinence from smoking after a period of enforced abstinence – systematic review, 
meta-analysis and analysis of behaviour change techniques with a focus on mental health. Psychological Medicine.  
Supplemental Material 
Table S1. Frequency of studies that used particular behaviour change techniques in their interventions 
Behaviour Change 
Technique 
Total 
(max n=10) 
Treatment as 
usual/control 
(max n=6) 
Inpatient 
intervention 
(max n=10) 
Post-discharge 
intervention 
(max n=7) 
Example description 
11.1 Pharmacological 
support 
9 5 8 5 The setting was a locked unit with a complete smoking ban that 
managed patients’ nicotine withdrawal with nicotine replacement 
therapy (NRT) during hospitalization. (Prochaska et al., 2014) 
1.2 Problem solving 6  4 2 CBT sessions teach smokers to recognize specific environmental and 
affective events (“triggers“) that occur prior to smoking and to identify 
behavioral and cognitive strategies to cope with these triggers. (Clarke 
et al., 2013) 
3.1 Social support 
(unspecified) 
6 3 5 4 The intervention group received one manually based individual session 
with an addiction therapist to explore motivation/ambivalence and 
provide a rationale for continuing smoking cessation post-discharge. 
(Gariti et al., 2002) 
9.2 Pros and cons 6  6  The project officer will conduct a brief (5-10 minutes) motivational 
interview by guiding the participant through a series of topics designed 
to motivate the participant towards positive health behaviour change, 
including: positives and negatives of smoking and quitting. (Stockings et 
al., 2011) 
5.3 Information about 
social and environ-
mental consequences 
5  5 1 Patients were encouraged to attend a group-oriented daily film series 
dealing with the hazards of smoking and how to quit successfully, and 
to discuss their reactions to the films. (Gariti et al., 2002) 
5.1 Information about 
health consequences 
5  5 1 The patients are given a great deal of education on tobacco and its 
effects on the brain and body. (Stuyt, 2015) a  
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Behaviour Change 
Technique 
Total 
(max n=10) 
Treatment as 
usual/control 
(max n=6) 
Inpatient 
intervention 
(max n=10) 
Post-discharge 
intervention 
(max n=7) 
Example description 
5.6 Information about 
emotional consequences 
5  5  In the Symptoms Management group they talk about how all the 
substances including tobacco play a role in anxiety or depression. 
(Stuyt, 2015) a  
8.2 Behaviour 
substitution 
5  4 1 Many change plans included specific steps for obtaining substitutes for 
cigarettes, such as gum or toothpicks. (Strong et al., 2012) 
1.4 Action planning 4  4 1 The final element of the intervention was to develop a change plan if 
appropriate. (Strong et al., 2012) 
1.1 Goal setting 
(behaviour) 
4  4  Patients were required upon admission to the hospital to acknowledge 
the smoke-free policy and agree to nicotine abstinence during 
treatment. (Joseph, 1993) 
9.3 Comparative 
imagining of future 
outcomes 
4  4  How would life be in 5 years’ time if you were still smoking and if you 
had quit smoking? What would it be like? (Stockings et al., 2014) a  
10.4 Social reward 4  2 2 What did client attempt? Reinforce attempts/accomplishments. (Clarke 
et al., 2013) a  
12.2 Restructuring the 
social environment 
4  3 1 There are two ways to use your social network to help you stay quit, or 
quit again if you have experienced a relapse. One is to talk to your 
friends and family. Find ex-smokers and get their perspectives. (Clarke 
et al., 2013) a   
12.3 Avoidance/ 
reducing exposure to 
cues for the behaviour 
4  3 1 AVOID high temptation situations. Don't go to places that you normally 
associate with smoking, at least for the first couple of days. (Clarke et 
al., 2013) a   
3.3 Social support 
(emotional) 
3  3  Make a pact to call someone several times a day if you need help or just 
a morale boost.  Also, agree that you will not smoke a cigarette until 
after you have talked with this person ...no matter what time it is or 
how late it is. (Clarke et al., 2013) a  
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Behaviour Change 
Technique 
Total 
(max n=10) 
Treatment as 
usual/control 
(max n=6) 
Inpatient 
intervention 
(max n=10) 
Post-discharge 
intervention 
(max n=7) 
Example description 
4.1 Instruction on how 
to perform a behaviour 
3  2 1 Groups will run on a rotating basis of one, one hour group for four 
weeks, and will follow an informational, group-oriented support and 
skills training format. (Stockings et al., 2014) 
4.2 Information about 
antecedents 
3  3  People tend to be consistent in the type of situations that are high risk 
for them. You can anticipate them, prepare for them, and rehearse in 
your mind how you are going to deal with them. (Clarke et al., 2013) a  
7.1 Prompts/cues 3  2 1 If there are certain times/places/people/actions that make you feel 
more motivated to quit, visit them more often! A diary can help identify 
these cues as well. (Stockings et al., 2014) a  
8.1 Behavioural 
practice/rehearsal 
3  3  If you have already learned RELAXATION skills, remember to use them 
when you are feeling stressed or irritable, even now, while you’re here. 
It’s good practice for when you go home. (Clarke et al., 2013) a  
10.3 Non-specific reward 3  2 1 Post quit sessions review/reinforce progress, revise plans for identifying 
high-risk situations, managing any side effects/withdrawal, review 
strategies for overcoming lapse events, and put in place reinforcement 
for successes. (Strong et al., 2012) 
11.2 Reduce negative 
emotions 
3  3  Have something that you can do with your hands and/or mouth when 
you are doing boring or repetitive tasks. Bring a book, a crossword 
puzzle, or magazines... anything to reduce boredom. (Clarke et al., 
2013) a  
12.1 Restructuring the 
physical environment 
3  3  Do not keep any cigarettes in your home, car or at work. If you do not 
have easy access it will be easier to avoid smoking. (Clarke et al., 2013) a  
12.4 Distraction 3  2 1 If you are with friends, ask them how their weekend was, or what they 
are planning to do later to take your mind off the craving. (Stockings et 
al., 2014) a  
12.5 Adding objects to 
the environment 
3  2 1 Avoid taking your cigarettes with you, but have your NRT on hand. 
(Stockings et al., 2014) a  
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Behaviour Change 
Technique 
Total 
(max n=10) 
Treatment as 
usual/control 
(max n=6) 
Inpatient 
intervention 
(max n=10) 
Post-discharge 
intervention 
(max n=7) 
Example description 
12.6 Body changes 3  3  You can avoid smoking by ALTERING YOUR BODILY REACTIONS. If you 
are smoking because you are feeling tense, anxious, uptight, or jittery, 
you can be taught ways to relax and to reduce anxiety using 
RELAXATION TRAINING instead of smoking. (Clarke et al., 2013) a  
13.2 Framing/reframing 3  3  However, the important thing for right now is to be aware that the road 
to permanent smoking cessation is a path that goes up and down. 
There will be many temptations the day you get out but within a week 
or two, the hills become less steep and the valleys are less deep, but 
don't expect a completely flat road for a while. (Clarke et al., 2013) a  
13.5 Identity associated 
with changed behaviour 
3  3  You are not a smoker again -- you're an ex-smoker who just has had a 
couple of cigarettes. Your levels of nicotine in your body are still very 
low. (Clarke et al., 2013) a  
15.2 Mental rehearsal of 
successful performance 
3  3  Imagine yourself on the outside encountering the Triggers and using 
your new coping skills to avoid smoking. (Clarke et al., 2013) a  
15.3 Focus on past 
success 
3  3  Keep in mind, you’ve been able to do without cigarettes while here. 
You’ve shown yourself that you can be without nicotine. (Clarke et al., 
2013) a  
15.4 Self-talk 3  3  One way to cope with negative self-talk is to tell yourself something 
positive that will help you not to smoke instead. (Clarke et al., 2013) a  
16.2 Imaginary reward 3  3  You need to have one particularly vivid image that you can always fall 
back on to help you through the tough times -- a motivating image that 
keeps you going. These motivating images need not necessarily be 
positive and need to be specific. For example, a positive image may be 
the pride your children will show when you are not smoking. (Clarke et 
al., 2013) a  
1.4 Action planning 2  2   b Prompt detailed planning of performance of the behaviour. Context 
may be environmental (physical or social) or internal (physical, 
emotional or cognitive). 
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Behaviour Change 
Technique 
Total 
(max n=10) 
Treatment as 
usual/control 
(max n=6) 
Inpatient 
intervention 
(max n=10) 
Post-discharge 
intervention 
(max n=7) 
Example description 
1.9 Commitment 2  2   b Ask the person to affirm or reaffirm statements indicating 
commitment to change the behaviour.  
2.1 Monitoring of 
behaviour without 
feedback 
2  1 1 Topics covered include: uptake, usage, problems and effectiveness of 
intervention supports (NRT, Quitline, community smoking cessation 
support groups), fortnightly review of NRT dosage, assistance with NRT 
use, monitoring and managing nicotine withdrawal symptoms, daily 
cigarette consumption, techniques to improve smoking outcomes, and 
general psychological support and encouragement. (Stockings et al., 
2014) 
2.3 Self-monitoring of 
behaviour 
2  1 1 Writing down the cigarettes you smoke every day is called self-
monitoring. Self-monitoring increases your awareness of your smoking 
patterns and puts you in a better position to change your habits and 
negative thoughts. (Clarke et al., 2013) a  
2.4 Self-monitoring of 
outcome(s) of behaviour 
2  2   b Establish a method for the person to monitor and record the 
outcome(s) of their behaviour as part of a behaviour change strategy.  
5.4 Monitoring of 
emotional consequences 
2  1 1 How did you feel right after smoking the cigarette? What negative self-
talk got to you? (Clarke et al., 2013) a  
6.2 Social comparison 2  2   b Draw attention to others’ performance to allow comparison with the 
person’s own performance.  
6.3 Information about 
other’s approval 
2  2   b Provide information about what other people think about the 
behaviour. The information clarifies whether others will like, approve or 
disapprove of what the person is doing or will do.  
8.7 Graded tasks 2  2   b Set easy-to-perform tasks, making them increasingly difficult, but 
achievable, until behaviour is performed. 
10.9 Self-reward 2  2   b Prompt self-praise or self-reward if and only if there has been effort 
and/or progress in performing the behaviour.  
13.4 Valued self-identity 2  2  What about you makes you think you can try your plan and have it 
work? (Clarke et al., 2013) a  
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Behaviour Change 
Technique 
Total 
(max n=10) 
Treatment as 
usual/control 
(max n=6) 
Inpatient 
intervention 
(max n=10) 
Post-discharge 
intervention 
(max n=7) 
Example description 
1.5 Review behaviour 
goal(s) 
1   1 Sometimes we set goals and later find they weren’t right for us. That’s 
ok. During the session today, you may decide on new goals, that’s up to 
you. (Clarke et al., 2013) a  
1.7 Review outcome 
goal(s) 
1   1 If not smoking: What new goals can you set? (Clarke et al., 2013) a  
1.8 Behavioural contract 1  1  This [agreement to nicotine abstinence] was confirmed in a written 
contract. (Joseph, 1993) 
2.2 Feedback on 
behaviour 
1  1  Provide personalised feedback using smoking-related information taken 
from the assessment. (Strong et al., 2012) 
2.5 Monitoring out-
come(s) of behaviour by 
others without feedback 
1  1  Breath carbon monoxide testing is utilized, in addition to urine drug 
screens for nicotine, alcohol, and other drug detection and 
breathalyzers for alcohol detection. (Stuyt, 2015) 
2.6 Biofeedback 1  1  We also teach coping skills such as biofeedback, tapping (Emotion 
Freedom Technique) and offer the NADA 5-point ear acupuncture 
protocol several times a week to help with cravings and anxiety or 
things that trigger them to use/smoke. (Stuyt, 2015) a  
4.3 Re-attribution 1   1 Adjust your thinking about the withdrawal symptoms. Focus on the 
biological component, not the emotional, for example try to change ‘I 
need a cigarette’ or ‘I can’t handle without a cigarette’ to ‘this is just a 
biological feeling of withdrawal, and it will pass soon’. (Stockings et al., 
2014) a  
6.1 Demonstration of 
the behaviour 
1  1  Patients were encouraged to attend a group-oriented daily film series 
dealing with the hazards of smoking and how to quit successfully, and 
to discuss their reactions to the films. (Gariti et al., 2002) 
7.4 Remove access to 
the reward 
1  1  Pick one or two situations in which you will not smoke. (Clarke et al., 
2013) a  
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Behaviour Change 
Technique 
Total 
(max n=10) 
Treatment as 
usual/control 
(max n=6) 
Inpatient 
intervention 
(max n=10) 
Post-discharge 
intervention 
(max n=7) 
Example description 
8.3 Habit formation 1  1  We recommend that you practice using relaxation at least once per day. 
You can also use these relaxation breaks (2-5 minutes) instead of your 
usual "smoke breaks" or "coffee breaks". (Clarke et al., 2013) a  
8.4 Habit reversal 1  1  Remember that smoking has been repeated "millions" of times. In 
order for a coping strategy to work it has to become as frequently used 
and as comfortable to you as smoking was in the past. (Clarke et al., 
2013) a  
11.3 Conserving mental 
resources 
1  1  You may want to jot down your positive thoughts on an index card and 
keep the card handy so you can refer to it (i.e. in your pocket). (Clarke 
et al., 2013) a  
13.3 Incompatible 
beliefs 
1  1  Explore broader goals and values of the participant and how smoking 
fits in with those. (Strong et al., 2012) 
Abbreviations: n: Number of studies 
 a  Quoted example is from additional information provided by a particular author in the form of intervention manuals or similar documents. 
b Examples used in studies not quoted due to a confidentiality and non-disclosure agreement in relation to the intervention manual for two trials (Hickman et al., 2015, 
Prochaska et al., 2014). The general BCT definition is shown instead (Michie et al., 2015). 
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A1. Final search strategies for all databases. 
MEDLINE 
1. exp "Tobacco Use"/ or exp "Tobacco Use Disorder"/  
2. (smok* or tobacco* or cigarette* or nicotine* or cigar*).ab,ti.  
3. exp Inpatients/ or exp Hospitalization/ or exp prisoner/ or exp Mental Health Services/ or exp Hospitals, Psychiatric/ or exp prisons/ or exp smoke-free policy/ or exp 
Substance Abuse Treatment Centers/  
4. (hospitali?ed or hospitali?ation* or inpatient* or in-patient* or inmate* or prison* or convict* or offender* or rehab* center or rehab* centre or smoke-free or smok* 
free or smokefree or ((smok* or tobacco) adj4 (ban or bans or banned or law or laws or policy or policies or prohibit* or restrict* or regulat* or legislat* or 
ordinance*))).ab,ti. 
5. exp "Tobacco Use Cessation"/  
6. ((smok* or tobacco or nicotine) adj3 (quit* or stop* or ceased or abstain* or abstin* or prevent* or cessation or reduction)).ab,ti.  
7. exp Recurrence/ or exp treatment outcome/  
8. (((relaps* or laps* or return to smok* or (smok* adj2 abstinence) or (abstinent adj2 smok*) or relapse) adj3 (prevent* or smok*)) or maintenance or recurrence).ab,ti.  
9. cohort studies/ or longitudinal studies/ or follow-up studies/ or prospective studies/ or retrospective studies/ or cohort.ti,ab. or longitudinal.ti,ab. or prospective.ti,ab. or 
retrospective.ti,ab.  
10. RANDOMIZED CONTROLLED TRIAL.pt.  
11. CONTROLLED CLINICAL TRIAL.pt.  
12. PRAGMATIC CLINICAL TRIAL.pt.  
13. CLINICAL TRIAL.pt.  
14. Meta analysis.pt.  
15. exp Clinical Trial/  
16. Random Allocation/  
17. randomized controlled trials/  
18. double blind method/  
19. single blind method/  
20. placebos/  
21. Research Design/  
22. ((clin$ adj5 trial$) or placebo$ or random$).ti,ab.  
23. ((singl$ or doubl$ or trebl$ or tripl$) adj5 (blind$ or mask$)).ti,ab.  
24. (volunteer$ or prospectiv$).ti,ab.  
25. exp Follow Up Studies/  
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26. exp Retrospective Studies/  
27. exp Prospective Studies/  
28. exp Evaluation Studies/ or Program Evaluation.mp.  
29. exp Cross Sectional Studies/  
30. Comparative study/  
31. exp Behavior therapy/  
32. exp Health Promotion/  
33. exp Community Health Services/  
34. exp Health Behavior/ or exp Health Education/  
35. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34  
36. smoking cessation.mp. or exp Smoking Cessation/  
37. "Tobacco Use Cessation"/  
38. "Tobacco Use Disorder"/  
39. Tobacco Smokeless/  
40. exp Tobacco Smoke Pollution/  
41. exp Tobacco/  
42. exp Nicotine/  
43. ((quit$ or stop$ or ceas$ or giv$) adj5 smoking).ti,ab.  
44. exp Smoking/pc, th  
45. 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44  
46. exp Smoking/ not 45  
47. 10 or 11 or 12  
48. 45 and 35  
49. 45 and 47  
50. (animals not humans).sh.  
51. ((36 or 37 or 38 or 39) and REVIEW.pt.) not 48  
52. 46 and 35  
53. (52 and 47) not 50  
54. 48 not 49 not 50  
55. (45 and 47) not 50  
56. 1 or 2 or 3 or 4  
57. 5 or 6  
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58. 7 or 8  
59. 9 or 55  
60. 56 and 57 and 58 and 59  
61. limit 60 to english  
62. limit 61 to adult 
 
EMBASE 
1. exp "tobacco use"/  
2. (smok* or tobacco* or cigarette* or nicotine* or cigar*).ab,ti.  
3. exp hospital patient/ or exp hospitalization/ or exp prison/ or exp prisoner/ or exp mental hospital/ or exp mental health service/ or exp smoking ban/ or exp drug 
dependence treatment/  
4. (hospitali?ed or hospitali?ation* or inpatient* or in-patient* or inmate* or prison* or convict* or offender* or rehab* center or rehab* centre or smoke-free or smok* 
free or smokefree or ((smok* or tobacco) adj4 (ban or bans or banned or law or laws or policy or policies or prohibit* or restrict* or regulat* or legislat* or 
ordinance*))).ab,ti. 
5. exp smoking cessation/ or exp smoking cessation program/  
6. ((smok* or tobacco or nicotine) adj3 (quit* or stop* or ceased or abstain* or abstin* or prevent* or cessation or reduction)).ab,ti.  
7. exp relapse/ or exp treatment outcome/ or treatment response/  
8. (((relaps* or laps* or return to smok* or (smok* adj2 abstinence) or (abstinent adj2 smok*) or relapse) adj3 (prevent* or smok*)) or maintenance or recurrence).ab,ti.  
9. cohort studies/ or longitudinal studies/ or follow-up studies/ or prospective studies/ or retrospective studies/ or cohort.ti,ab. or longitudinal.ti,ab. or prospective.ti,ab. or 
retrospective.ti,ab.  
10. (RANDOM$ or FACTORIAL$ or (CROSSOVER$ or CROSS OVER$) or PLACEBO$ or (DOUBL$ adj BLIND$) or (SINGL$ adj BLIND$) or ASSIGN$ or ALLOCAT$ or 
VOLUNTEER$).ti,ab.  
11. CROSSOVER PROCEDURE/ or DOUBLE BLIND PROCEDURE/ or RANDOMIZED CONTROLLED TRIAL/ or SINGLE BLIND PROCEDURE/  
12. 10 or 11  
13. SMOKING CESSATION.mp.  
14. exp SMOKING CESSATION/  
15. exp SMOKING/  
16. ((QUIT$ or STOP$ or CEAS$ or GIV$ or PREVENT$) adj SMOK$).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword]  
17. exp PASSIVE SMOKING/ or exp SMOKING HABIT/ or exp CIGARETTE SMOKING/ or exp "SMOKING CESSATION"/dem, der  
18. 13 or 14 or 15 or 16 or 17  
19. 12 and 18  
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20. 1 or 2 or 3 or 4  
21. 5 or 6  
22. 7 or 8  
23. 9 or 19  
24. 20 and 21 and 22 and 23  
25. limit 24 to english  
26. limit 25 to adult 
 
PsycInfo 
1. exp tobacco smoking/  
2. (smok* or tobacco* or cigarette* or nicotine* or cigar*).ab,ti.  
3. exp Hospitalized Patients/ or exp Hospitalization/ or exp prisoners/ or exp drug rehabilitation/ or smoke free.mp. 
4. (hospitali?ed or hospitali?ation* or inpatient* or in-patient* or inmate* or prison* or convict* or offender* or rehab* center or rehab* centre or smoke-free or smok* 
free or smokefree or ((smok* or tobacco) adj4 (ban or bans or banned or law or laws or policy or policies or prohibit* or restrict* or regulat* or legislat* or 
ordinance*))).ab,ti. 
5. exp smoking cessation/  
6. ((smok* or tobacco or nicotine) adj3 (quit* or stop* or ceased or abstain* or abstin* or prevent* or cessation or reduction)).ab,ti.  
7. exp treatment outcomes/ or exp "Relapse (Disorders)"/  
8. (((relaps* or laps* or return to smok* or (smok* adj2 abstinence) or (abstinent adj2 smok*) or relapse) adj3 (prevent* or smok*)) or maintenance or recurrence).ab,ti.  
9. ((cohort or longitudinal or prospective or retrospective).ti,ab,id. or longitudinal study.md. or prospective study.md. or retrospective study.md.) not "Literature 
Review".md.  
10. SMOKING CESSATION.mp. or exp SMOKING CESSATION/  
11. (ANTISMOKING or ANTI SMOKING).mp.  
12. (QUIT$ or CESSAT$).mp.  
13. (ABSTIN$ or ABSTAIN$).mp.  
14. (CONTROL$ adj SMOK$).mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures]  
15. exp BEHAVIOR MODIFICATION/  
16. 11 or 12 or 13 or 14 or 15  
17. TOBACCO SMOKING/  
18. (SMOK$ or CIGAR$ or TOBACCO$).mp.  
19. PREVENTION/  
20. 17 or 18  
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21. 16 and 20  
22. 19 and 20  
23. 10 or 21 or 22  
24. 1 or 2 or 3 or 4  
25. 5 or 6  
26. 7 or 8  
27. 9 or 23  
28. 24 and 25 and 26 and 27  
29. limit 28 to english  
30. limit 29 to adult 
 
CINAHL 
S1 (MH "Smoking+")  
S2 TI (smok* OR tobacco* OR cigarette* OR nicotine* OR cigar*) OR AB (smok* OR tobacco* OR cigarette* OR nicotine* OR cigar*)  
S3 (MH "Inpatients") OR (MH "Psychiatric Patients+")  
S4 (MH "Prisoners") OR (MH "Correctional Health Services") OR (MH "Correctional Facilities")  
S5 TI (hospitali?ed or hospitali?ation* or inpatient* or in-patient* or inmate* or prison* or convict*) OR AB (hospitali?ed or hospitali?ation* or inpatient* or in-patient* or 
inmate* or prison* or convict*)  
S6 (MH "Smoking Cessation") OR (MH "Smoking Cessation Programs") OR (MH "Smoking Cessation Assistance (Iowa NIC)") OR (MH "Tobacco Use Cessation Products+")  
S7 TI ((smok* N cessation) or (smok* N reduction) or stop smoking or (tobacco N2 cessation) or (tobacco N2 reduction) or (nicotine* N2 cessation) or (nicotine* N2 
reduction) or (quit N smok*)) OR AB ((smok* N cessation) or (smok* N reduction) or stop smoking or (tobacco N2 cessation) or (tobacco N2 reduction) or (nicotine* N2 
cessation) or (nicotine* N2 reduction) or (quit N smok*)) 
S8 (MH "Recurrence")  
S9 TI (relaps* or laps* or return to smok* or (smok* N abstinence) or (abstinent N smok*)) OR AB (relaps* or laps* or return to smok* or (smok* N abstinence) or (abstinent 
N smok*)) 
S10 (TI longitudinal* OR AB longitudinal* OR TI prospective OR AB prospective OR TI cohort OR AB cohort OR TI follow-up OR AB follow-up OR TI follow up OR AB follow up 
OR TI baseline OR AB baseline OR TI wave* OR AB wave* OR TI panel OR AB panel OR TI predict* OR AB predict*) 
S11 ( TX (random* OR factorial* OR placebo* OR assign* OR allocat*) ) OR ( TX (trial and (control* OR comparative)) ) OR TX "treatment arm" OR TX "control group*" OR ( 
MH (Random assignment OR Clinical Trials+ OR Quantitative Studies) ) OR TX RCT OR MH Placebos  
S12 S1 OR S2 OR S3 OR S4  
S13 S5 OR S6 OR S7  
S14 S8 OR S9  
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S15 S10 OR S11  
S16 S12 AND S13 AND S14 AND S15  
 
Web of Science 
#7 (#6 AND #5 AND #4 AND #1) AND LANGUAGE: (English)  
#6 #3 OR #2  
#5 TS= clinical trial* OR TS=research design OR TS=comparative stud* OR TS=evaluation stud* OR TS=controlled trial* OR TS=follow-up stud* OR TS=prospective  stud* OR 
TS=random* OR TS=placebo* OR TS=(single blind*) OR TS=(double blind*)  
#4 ti=(relaps* or laps* or return to smok* or (smok* near/2 abstinence) or (abstinent near/2 smok*) or relapse near/3 (prevent* or smok*) or maintenance or  recurrence)  
#3 ti=((smok* or tobacco or nicotine) near/3 (quit* or stop* or ceased or abstain* or abstin* or prevent* or cessation or reduction))  
#2 ti=(hospitali?ed or hospitali?ation* or inpatient* or in-patient* or inmate* or prison* or convict* or offender* or rehab* center or rehab* centre or smoke-free or smok* 
free or smokefree or ((smok* or tobacco) near/4 (ban or bans or banned or law or laws or policy or policies or prohibit* or restrict* or regulat* or legislat* or 
ordinance*)))  
#1 ts=(smok* or tobacco* or cigarette* or nicotine* or cigar*) 
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